Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.520
-0.230 (-4.84%)
At close: Mar 26, 2026, 4:00 PM EDT
4.500
-0.020 (-0.44%)
After-hours: Mar 26, 2026, 7:59 PM EDT
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $321.59 million as of March 26, 2026. Its market cap has increased by 994.57% in one year.
Market Cap
321.59M
Enterprise Value
277.63M
1-Year Change
994.57%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $321.59M, an increase of 1,412.49%. That is a compound annual growth rate of 65.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 321.59M | 132.00% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 346.70M |
| Immuneering | 345.57M |
| Armata Pharmaceuticals | 343.68M |
| PepGen | 342.12M |
| Kyverna Therapeutics | 342.05M |
| Bicycle Therapeutics | 332.50M |
| Climb Bio | 331.99M |
| Puma Biotechnology | 329.68M |